Shifts the balance of certain proteins inside cells toward survival signals and reduces activity of a protein involved in cell death, helping protect cells from dying off
Notably, it has been used in Germany as an approved treatment for diabetic neuropathy for decades
He Z, Zhang H, Li X, Tu S, Wang Z, Han S, et al
Additionally, Dihexa has been shown to increase the levels of brain-derived neurotrophic factor (BDNF), a protein essential for neuronal growth and survival, further supporting its cognitive enhancement properties
BPC-157 is most often considered when: Recovery from a musculoskeletal injury has stalled beyond the expected timeline Inflammation appears to be a persistent driver rather than an acute protective response Gut lining integrity is a concern as part of a broader inflammatory or digestive picture The patient is a reasonable candidate for physician-supervised peptide therapy based on health history and risk profile It is not appropriate when there is an unresolved structural question that imaging should answer first, when there are acute red flag symptoms warranting urgent evaluation, or when the individual is hoping a peptide will substitute for rehabilitation and load management
